Cargando…
Therapeutic strategies to enhance immune response induced by multiple myeloma cells
Multiple myeloma (MM)as a haematological malignancy is still incurable. In addition to the presence of somatic genetic mutations in myeloma patients, the presence of immunosuppressive microenvironment greatly affects the outcome of treatment. Although the discovery of immunotherapy makes it possible...
Autores principales: | Liu, Zhaoyun, Yang, Chun, Liu, Xiaohan, Xu, Xintong, Zhao, Xianghong, Fu, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232766/ https://www.ncbi.nlm.nih.gov/pubmed/37275861 http://dx.doi.org/10.3389/fimmu.2023.1169541 |
Ejemplares similares
-
Adenosinergic axis and immune checkpoint combination therapy in tumor: A new perspective for immunotherapy strategy
por: Liu, Zhaoyun, et al.
Publicado: (2022) -
Immune checkpoint inhibitors for multiple myeloma immunotherapy
por: Liu, Zhaoyun, et al.
Publicado: (2023) -
Predictive Role of Immune Profiling for Survival of Multiple Myeloma Patients
por: Zhaoyun, Liu, et al.
Publicado: (2021) -
PB2136: THE VALUE OF PERIPHERAL BLOOD LYMPHOCYTE SUBSETS IN PREDICTING THE PROGNOSIS OF NEWLY DIAGNOSED MULTIPLE MYELOMA
por: Liu, Zhaoyun, et al.
Publicado: (2023) -
Pim-2 Kinase Regulates Energy Metabolism in Multiple Myeloma
por: Liu, Zhaoyun, et al.
Publicado: (2022)